MEDNAX (MD) Tops Q2 EPS by 1c, Revenues Beat

Go back to MEDNAX (MD) Tops Q2 EPS by 1c, Revenues Beat

Credit Suisse Upgrades Mednax (MD) to Outperform

August 3, 2018 6:13 AM EDT

Credit Suisse upgraded Mednax (NYSE: MD) from Neutral to Outperform with a price target of $55.00 (from $47.00).

For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.

Shares of Mednax closed at $45.12 yesterday.

... More

Mednax (MD) PT Lowered to $48 at Mizuho Securities

August 3, 2018 5:22 AM EDT

Mizuho Securities lowered its price target on Mednax (NYSE: MD) to $48.00 (from $50.00) while maintaining a Neutral rating.

... More